UBS Group
INSM icon

UBS Group’s Insmed INSM Stock Holding History

UBS Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+2,016
New +$244K ﹤0.01% 6745
2026
Q1 		– Sell
-37,600
Closed -$6.54M – 10817
2025
Q4 		$6.54M Hold
37,600
– – ﹤0.01% 3748
2025
Q3 		$5.41M Buy
+37,600
New +$4.61M ﹤0.01% 3955
2025
Q2 		– Sell
-5,000
Closed -$381K – 10536
2025
Q1 		$381K Buy
5,000
+1,200
+32% +$91.8K ﹤0.01% 6075
2024
Q4 		$262K Buy
+3,800
New +$274K ﹤0.01% 6289
2022
Q4 		– Sell
-9,000
Closed -$194K – 10914
2022
Q3 		$194K Buy
+9,000
New +$216K ﹤0.01% 5107

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

UBS Group's INSM Position: Q2 2026 in Review

UBS Group increased its Insmed (INSM) stake by 49% in Q2 2026, buying an estimated $103M and bringing the position to 2,584,446 shares worth $276M. The position accounts for 0.04% of the portfolio, ranked #508.

UBS Group first reported a position in INSM in Q4 2014 and has held it in 47 quarters since. The position peaked at $325M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • UBS Group held 2,584,446 shares of Insmed worth $276M as of Q2 2026.
  • UBS Group bought 846,965 Insmed shares in Q2 2026, an estimated $103M.
  • Insmed made up 0.04% of UBS Group's portfolio in Q2 2026, its #508 holding.
  • UBS Group first reported a position in Insmed in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Insmed position peaked at $325M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.